Twelve weeks treatment with the DPP-4 inhibitor sitagliptin improves glycaemic control, but does not improve GLP-1 secretion, in patients with type 2 diabetes - a randomised trial

K. Aaboe, F.K. Knop, Tina Vilsbøll, Carolyn F. Deacon, Jens Juul Holst, S. Madsbad, T. Krarup

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskning

Konference

KonferenceTwelve weeks treatment with the DPP-4 inhibitor sitagliptin improves glycaemic control, but does not improve GLP-1 secretion, in patients with type 2 diabetes - a randomised trial
Periode29/11/2010 → …

Bibliografisk note

JSEPSuppl. 1
Udgivelsesdato: 2009
Volumne: 52

Citationsformater